Key result
Elevated GGT is linked to ~42% higher hemorrhagic stroke risk and increased ischemic stroke risk.
Why the study?
Although gamma-glutamyl transpeptidase (GGT) serves as a prognostic biomarker in cardiovascular diseases, its association with ischemic and hemorrhagic stroke required evaluation.
Do elevated gamma-glutamyl transpeptidase (GGT) levels increase the risk of ischemic and hemorrhagic strokes?
Meta-Analysis
Do elevated gamma-glutamyl transpeptidase (GGT) levels increase the risk of ischemic and hemorrhagic strokes?
Relative Risk: 1.42 (95% CI 1.01–1.99)
Elevated GGT levels are associated with a significantly increased risk of both ischemic and hemorrhagic strokes, suggesting its potential utility as a prognostic biomarker.
Supports GGT as a prognostic stroke marker; extends observational meta-analyses but leaves causal inference and practice change open.
Stroke is influenced by numerous factors, both modifiable and non-modifiable. Among these, gamma-glutamyl transpeptidase (GGT) serves as a prognostic biomarker in cardiovascular diseases and, within this context, in neurological conditions like stroke. To determine whether an association exists between GGT and both ischemic and hemorrhagic strokes. A systematic and comprehensive literature search was conducted across 5 databases, encompassing studies published from their inception to January 28, 2024, following a population, exposure, comparator, outcome, and study (PECOS) framework. Ten primary studies meeting the eligibility criteria were selected. Our findings, based on a meta-analysis of the ten studies, indicate an increased risk of ischemic and hemorrhagic strokes in patients with elevated GGT levels, after excluding outliers. The analysis demonstrated a significant association, with a relative risk of 1.42 (95%CI: 1.01–1.99; I2 = 19%) for hemorrhagic stroke and 1.22 (95%CI: 1.10–1.36; I2 = 49%) for ischemic stroke. Our study reveals an elevated risk of stroke in patients with high GGT levels, demonstrating a 42% higher likelihood of hemorrhagic stroke and a 22% increased risk of ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Vásquez-Tirado et al. (2025) conducted a meta-analysis in Stroke. Elevated gamma-glutamyl transpeptidase (GGT) levels vs. Lower GGT levels was evaluated on Hemorrhagic stroke (RR 1.42, 95% CI 1.01-1.99). Elevated gamma-glutamyl transpeptidase levels were associated with an increased risk of hemorrhagic stroke (RR 1.42; 95% CI 1.01-1.99) and ischemic stroke (RR 1.22; 95% CI 1.10-1.36).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: